Screening Women With Prior HPV for Anal Neoplasia
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta z historią wykrytych zaawansowanych zmian przedrakowych w narządach płciowych (szyjka macicy, srocie, pochwa) lub raka tych miejsc
- •Ujemny wynik testu na HIV
- •Wiek 35 lat lub więcej
- •Pacjentka placówek Mount Sinai Health System lub Harris Health System w Houston
- •Posługuje się językiem angielskim lub hiszpańskim
✗ Disqualifies
- •Wcześniejsze badanie wysokorozdzielcze odbytnicy
Simplified criteria — AI translation
Trial details
- Minimum age
- 35 Years
- Last updated (source)
- October 13, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (3)
Icahn School of Medicine at Mount Sinai
New York, United States
Medical University of South Carolina
Charleston, United States
University of Texas M D Anderson Cancer Center
Houston, United States
Trial contact
Daniela Solis
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.